Submission Details
| 510(k) Number | K230994 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 07, 2023 |
| Decision Date | May 04, 2023 |
| Days to Decision | 27 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K230994 is an FDA 510(k) clearance for the Alinity i STAT High Sensitivity Troponin-I, a Immunoassay Method, Troponin Subunit (Class II — Special Controls, product code MMI), submitted by Abbott Laboratories Diagnostics Division (Abbott Park, US). The FDA issued a Cleared decision on May 4, 2023, 27 days after receiving the submission on April 7, 2023. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1215.
| 510(k) Number | K230994 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 07, 2023 |
| Decision Date | May 04, 2023 |
| Days to Decision | 27 days |
| Submission Type | Special |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | MMI — Immunoassay Method, Troponin Subunit |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1215 |